The CISNET prostate group has been adapting and applying models of prostate cancer natural history and survival to understand how changes in prostate cancer screening and treatment impact disease outcomes. Kaiser Permanente will participate in the third funding cycle of this project by conducting targeted analyses that can be used within the overall CISNET models, specifically focusing on outcomes among men with low-risk and local disease.
Modeling to Improve Prostate Cancer Outcomes across Diverse Populations
Investigator: Van Den Eeden, Stephen
Funder: National Cancer Institute
